Multi drug resistance and β-lactamase production by Klebsiella pneumoniae

African Journal of Biotechnology

Volumn 6, Issue 15, 2007, Pages 1791-1793

  Khadri C, Habeeb ^a   Surekha, S ^a   Lakshmi, S ^a   Narasimha, G ^b  

^a Anantapur Government Medical College   (India)

^b National PG College   (India)

Author keywords

Drug resistance; ESBL production; Klebsiella pneumoniae

Indexed keywords

AMIKACIN; AMPICILLIN; AZTREONAM; CEFOTAXIME; CEFOXITIN; CEFTAZIDIME; CEFTRIAXONE; COTRIMOXAZOLE; EXTENDED SPECTRUM BETA LACTAMASE; GENTAMICIN; IMIPENEM; TETRACYCLINE;

ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL STRAIN; BACTERIUM ISOLATION; CHILDHOOD DISEASE; ENZYME SYNTHESIS; ESCHERICHIA COLI K 12; HUMAN; INFANT; INTESTINE INFECTION; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NEWBORN; NONHUMAN; PLASMID; PRESCHOOL CHILD; STRAIN DIFFERENCE;

ESCHERICHIA COLI; KLEBSIELLA PNEUMONIAE;

EID: 34548056975     PISSN: None     EISSN: 16845315     Source Type: Journal    
DOI: 10.5897/ajb2007.000-2264     Document Type: Article

References (21)

1. Abdul Rahaman KA, Kumar A (2005). Extended spectrum β-lactamases in urinary isolates of Escherichia coli, Klebsiella pneumoniae and other gram negative bacteria in a hospital. Saudi Med. J. 26(6): 956-959.
2. Abigail S, Mathai E, Jesudason MV, John TJ (1995). Ceftazidime resistance among Klebsiella pneumoniae in South India, Indian J. Med. Res. 102: 53-55.
3. Bal S (2000). β-lactamase mediated resistance in hospital acquire urinary tract infection. Hosp. Today 5: 96-101.
4. Brun-Buisson CB, Legrand P, Phillippon A, Montravers F, Ansquer M, Duval J ( 1987). Transferable enzymatic resistant to third generation cephalosporin during nosocomial out breaks of multi resistant Klebsiella pneumoniae. Lancet. 2: 302-306.
5. Hobson RP, Mackenzie GM, Gould IM (1996). An out breaks of multiple resistant Klebsiella pneumoniae in the Grampian region of Scotland. J. Hosp. Infect. 33: 249-62.
6. Jacoby GA, Han P (1996) Detection of extended spectrum β-lactamases in clinical isolates of Klesiella pneumoniae and E.coli. pp. 908-911.
7. Jarlier V, Nicolas MH, Fournier G, Phillippon A (1988). Extended broadspectrum β-lactamases conferring transferable resistance to newer β- lactamases agents in enterobacteriaceae; Hospital prevalence and susceptibility pattern. Rev. Infect. Dis. 10: 867-878.
8. Jacoby GA, Sutton L (1999). Properties of plasmids responsible for production of extended spectrum β macadamizes. Antimicron Agents Chemother. pp. 164-169.
9. Jones RN, Kugler KC, Pfaller MA, Winokur PL (1999). Characterization of pathogens causing Urinary Tract Infection in hospital in North America; Results from the SENTRY, Antimicrobial surveillance program. SENTRY surveillance group. Diagn. Mirobiol. Infect. Dis. 35: 55-63.
10. Koneman EW, Allen SD, Janda WM, Schreekenberger PC, Winn WC (1992). The enterobacteriaceae in; color atlas and text book of diagnostic microbiology 4th ed, Philadelphia; J.B. Lipincott Co. pp. 105-184.
11. Legakis NJ, Tzouvelekis LS, Hatzoudis G, Tzelepi E, Gourkou A, Pitt TL (1995) Klebsiella pneumoniae infections in Greek hospitals. Dissemination of plasmids encoding an SHV-5 type β-lactamase. J. Hosp. Infect. 31: 177-187.
12. Livermore DM (1998). β-lactamase mediated resistance and opportunities for its control. J. Antimicrob. Chemother. 41: 25-41.
13. th edition. Approval standard NCCLS, document M2- A7, Vol. 20; Wayne.
14. Padmini B, Applaraju BS (2004). Extended spectrum β-lactamases in urinary isolates of E.coli and Klebsiella pneumoniae prevalence and susceptibility pattern in a tertiary care hospital. Indian J. Med. Microbiol. 22: 172-174.
15. Paterson DL, Motiapatra SK, Vongottberg A (1997). Klebsiella pneumoniae bacterium impact of extended spectrum β-lactamases (ESBL) production in a global study of 216 patients (abst) in; program and abstract of the 37th inter science conference on antimicrobial agents and chemotherapy Washington, DC; Am. Soc. Microb. pp. 328.
16. Philippon A, Labia R, Jacoby G (1989). Extended spectrum β-lactamases, Antimicrob. Agents Chemother. 33: 1131-1136.
17. Podschu R, Ullmann U (1998). Klebsiella spp. as nosocomial pathogens; Epidemiology, Taxonomy, Typing Methods and Pathogenicity factors. Clin. Microbiol. Rev. 11: 589-603.
18. Rice LE (1999) Successful interventions for gram negative resistance to extended spectrum β-lactamases antibiotics. Pharmacotherapy. 19: 120-128.
19. Subha A, Devi VR, Ananthan S (2003). AmpC β-lactase producing multi drug resistant strains of klebsiella spp, and Escherichia coli isolated from childrens under five in Chennai, India. Indian J. Med. Res. 117: 13-18.
20. Sirot D (1995). Extended spectrum plasmid mediated β-lactamases. J. Antimicrob. Chemother. 36: (suppl) 19-34.
21. Steward CD, Rasheed JK, Hubert SK, Biddle JW, Raney PM, Anderson G (2001). Characterization of clinical isolates of Klebsiella pneumoniafrom 19 laboratories using the National Committee for Clinical Laboratory Standards, extended spectrum β-lactamases detection methods. J. Clin. Microbiol. 39: 2864-2872.